Compounds with hcv replication inhibition activity

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 235/76 (2006.01) A61K 31/201 (2006.01) A61K 31/405 (2006.01) A61P 31/12 (2006.01) C07C 251/38 (2006.01) C07C 251/58 (2006.01)

Patent

CA 2515370

It is intended to provide a medicinal composition for preventing or treating viral infection. A medicinal composition containing a compound, which has an extremely potent anti-HCV activity and an HCV amplification inhibitory effect and shows little cytotoxicity in vivo, is highly useful as a preventive/remedy for HCV.

La présente invention concerne une composition pharmaceutique pour prévenir ou traiter une infection virale. La composition pharmaceutique comprend un composé qui a une activité anti-VHC extrêmement puissante et un effet d'inhibition de l'amplification de VHC, et a une cytotoxicité faible in vivo, et s'avère très utile en tant qu'agent de prévention/remède pour le VHC.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compounds with hcv replication inhibition activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds with hcv replication inhibition activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds with hcv replication inhibition activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1681225

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.